$37.10
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington and currently employs 155 full-time employees. The firm facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the cell and gene therapy market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal closed systems are purpose-built rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The firm's ThawSTAR product line comprises a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Country

US

CEO

Mr. Roderick de Greef

IPO date

1989

Employees

155

ISIN

US09062W2044

Key stats

Open

$38.00

Volume

744.79K

Market cap

$1.81B

Prev. close

$37.10

Impl / hst vl

-

Open interest

$0.00

$36.29

Day’s Range

$38.00

$17.86

52W Range

$38.10

Valuation

61
Valuation score
Undervalued
P/E
-
P/S
16.76
P/B
4.10
Current ratio
9.69
Debt / Equity
-0.06
ROE
15.28%
Gross margin
64.24%
Income growth
3,703.04%
FCF growth
-887.99

Analysts estimates

Consensus rating
Hold

The average rating from top 8 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$31.75
The top 10 analysts forecasts that 12-month price may decrease by 14.43%, with a low of $30.30 and a high of $34.65
$30.30
Low
$31.75
Avg
$34.65
High
Current price

Earnings

Q2 ‘26 revenue
$28.47M
Q2 ‘26 net income
$45.10M
Revenue
Net income
Previous EPS
$0.02
Estimate EPS
$0.03
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply